Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haplo‐identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT

21 Feb 2021

Abstract excerpt

Allogeneic hematopoietic cell transplantation (HCT) is the only curative option for bone marrow failure or hematopoietic malignant diseases for Fanconi anemia (FA) patients. Although results have improved over the last decades, reaching more than 90% survival when a human leukocyte antigen (HLA)-identical donor is available, alternative HCT donors are still less reported. We compared HCT outcomes using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Hematopoietic Stem Cell Transplantation
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33606297
DOI: 10.1002/ajh.26135

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haplo‐identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMTPMID 33606297Read ↗

Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology).Semantic proximity Read ↗

Alternative donor hematopoietic cell transplantation for Fanconi anemiaSemantic proximity Read ↗

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.Semantic proximity Read ↗

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsSemantic proximity Read ↗

How I manage patients with Fanconi anaemia.Semantic proximity Read ↗

Fanconi AnemiaSemantic proximity Read ↗

How I treat MDS and AML in Fanconi anemiaSemantic proximity Read ↗

Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature reviewSemantic proximity Read ↗

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.Semantic proximity Read ↗

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of HematologySemantic proximity Read ↗

HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabineSemantic proximity Read ↗

Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.